Dear Nanomedicine Community Member, SFNano is pleased to share the following news:If you have a promising project in Nanomedicine, don’t miss out the opportunity to apply to the TAB – Nanomedicine Translation Advisory Board until the 31th of July 2016!

Huge benefits!
The TAB provides you unique, free of charge access to high-level experts, who will advise and guide you to accelerate your project to the market. The TAB wants to help you to make the right strategic choices at the right time, reducing risks and maximizing the chances of success.The two previous calls of the TAB demonstrated the interest of the instrument. We have received a total of 42 applications from 15 countries in Europe and EU Associated Countries. Half of the projects have been qualified and are currently benefiting from mentoring and follow up over time. But the most important for us is that the value of TAB is now recognised by its first beneficiaries (testimonials)
Who can apply? 
European companies, public and private research groups / individuals working on promising Nanomedicine projects at any stage of development.
Who are the high-level experts?
The TAB experts are coming from the pharma and healthcare industries, including biotech and nanotech entrepreneurs, and former top managers at large corporations. All the experts have a sound track record in translating promising concepts to market success.
What is the process?

  1. Hard selection based on application files
  2. Individual mentoring during live sessions (TAB-In Sessions)
  3. Follow up of selected projects (follow up content depending on specific needs, and until the moment that chances of success exist)

What are the TAB-In Sessions?
The TAB-In Sessions are the entry point for projects selected to benefit from the TAB. They provide beneficiaries the unique opportunity of benefiting from face-to-face meetings to get experts’ initial feedback and recommendations. The TAB-In Sessions should normally take place during relevant larger events or business conferences (e.g. ETPN Annual Event, CLINAM, Bio-Europe). The ongoing call will provide selected projects with access to the TAB-In Sessions to be held on the 14th of October, in Heraklion, Crete (Greece), in the framework of the ETPN Annual Event (12 – 14 October 2016).
Apply here! 
Further information about the TAB can be found at http://www.nanomedtab.eu/
TAB PR [197 KB]
TAB Flyer [1.296 KB]